文献速递心脑血管急症重症综合管理与镇静镇痛

COVID-19 大流行与急性心肌梗死治疗及结局中的相关不平等

The COVID-19 Pandemic and Associated Inequities in Acute Myocardial Infarction Treatment and Outcomes.
PubMed 文献 · JAMA Netw Open · 2023-08-01
一句话结论医院COVID-19负担高(>30%)时NSTEMI患者死亡与出院至非家庭机构 odds 升高、血运重建 odds 降低,但种族和民族间不平等未显著扩大。

这项横断面研究使用2016年1月至2020年11月的Medicare数据,纳入1 319 273例急性心肌梗死住院患者,以医院每周COVID-19住院患者比例作为医疗中断的代理指标,采用中断时间序列分析。结果显示,在COVID-19负担高(>30%)的周住院的NSTEMI患者,校正后死亡 odds 升高51%(aOR 1.51;95% CI 1.29-1.76;P<.001),出院至非家庭机构 odds 升高32%(aOR 1.32;95% CI 1.15-1.52;P<.001),血运重建 odds 降低27%(aOR 0.73;95% CI 0.64-0.83;P<.001)。Black NSTEMI患者医院COVID-19负担每增加10%,死亡 odds 额外增加7%(aOR 1.07;95% CI 1.00-1.15;P=.04),但无临床意义。Hispanic与White NSTEMI患者之间无差异,STEMI患者中医院COVID-19负担与结局或血运重建使用无关。作者认为需额外努力减轻COVID-19大流行对AMI患者结局的影响。

要点

  • NSTEMI患者在医院COVID-19负担>30%的周住院,校正后死亡 odds 升高51%(aOR 1.51;95% CI 1.29-1.76;P<.001)。
  • 同期NSTEMI患者出院至非家庭机构 odds 升高32%(aOR 1.32;95% CI 1.15-1.52;P<.001),血运重建 odds 降低27%(aOR 0.73;95% CI 0.64-0.83;P<.001)。
  • Black NSTEMI患者医院COVID-19负担每增加10%,死亡 odds 额外增加7%(aOR 1.07;95% CI 1.00-1.15;P=.04),作者称无临床意义。
  • Hispanic与White NSTEMI患者之间基于医院COVID-19负担的不良结局无差异升高。
  • STEMI患者中医院COVID-19负担与结局改变或血运重建使用无关,总体及按种族和民族分组均如此。

适用人群与场景

  • 2016年1月至2020年11月因急性心肌梗死住院的Medicare患者,包括NSTEMI和STEMI。
  • 按种族和民族分为Hispanic、非Hispanic Black和非Hispanic White。

研究设计与关键结果

  • 研究类型为横断面研究,使用中断时间序列分析,数据来自Medicare,纳入1 319 273例AMI住院(女性579 817例[44.0%];Black 122 972例[9.3%]、Hispanic 117 668例[8.9%]、White 1 078 633例[81.8%];平均[SD]年龄77[8.4]岁)。
  • 暴露为医院每周COVID-19住院患者比例,作为大流行期间医疗中断的代理指标。
  • NSTEMI总体:与在大流行前住院的患者相比,在医院COVID-19负担高(>30%)的周住院的患者,校正后死亡 odds 升高51%(aOR 1.51;95% CI 1.29-1.76;P<.001),出院至非家庭机构 odds 升高32%(aOR 1.32;95% CI 1.15-1.52;P<.001),血运重建 odds 降低27%(aOR 0.73;95% CI 0.64-0.83;P<.001)。
  • Black NSTEMI患者:医院COVID-19负担每增加10%,死亡 odds 额外增加7%(aOR 1.07;95% CI 1.00-1.15;P=.04),作者称无临床意义;与White患者相比,再入院、出院至非家庭机构或血运重建率无增加。
  • Hispanic与White NSTEMI患者之间,基于医院COVID-19负担的不良结局无差异升高。
  • STEMI总体及按种族和民族分组:医院COVID-19负担增加与结局改变或血运重建使用无关。

证据类型、等级与局限

  • 证据类型:横断面研究,使用中断时间序列分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,需额外努力减轻COVID-19大流行对AMI患者结局的影响,尤其当医院COVID-19负担大幅增加时。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: The COVID-19 pandemic disrupted usual care for emergent conditions, such as acute myocardial infarction (AMI). Understanding whether Black and Hispanic individuals experiencing AMI had greater increases in poor outcomes compared with White individuals during the pandemic has important equity implications.

OBJECTIVE: To investigate whether the COVID-19 pandemic was associated with increased disparities in treatment and outcomes among Medicare patients hospitalized with AMI.

DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study used Medicare data for patients hospitalized with AMI between January 2016 and November 2020. Patients were categorized as Hispanic, non-Hispanic Black, and non-Hispanic White. The association between race and ethnicity and outcomes as a function of the proportion of hospitalized patients with COVID-19 was evaluated using interrupted time series. Data were analyzed from October 2022 to June 2023.

EXPOSURE: The main exposure was a hospital's proportion of hospitalized patients with COVID-19 on a weekly basis as a proxy for care disruption during the pandemic.

MAIN OUTCOMES AND MEASURES: Revascularization, 30-day mortality, 30-day readmission, and nonhome discharges.

RESULTS: A total of 1 319 273 admissions for AMI (579 817 females [44.0%]; 122 972 Black [9.3%], 117 668 Hispanic [8.9%], and 1 078 633 White [81.8%]; mean [SD] age, 77 [8.4] years) were included. For patients with non-ST segment elevation MI (NSTEMI) overall, the adjusted odds of mortality and nonhome discharges increased by 51% (adjusted odds ratio [aOR], 1.51; 95% CI, 1.29-1.76; P < .001) and 32% (aOR, 1.32; 95% CI, 1.15-1.52; P < .001), respectively, and the odds of revascularization decreased by 27% (aOR, 0.73; 95% CI, 0.64-0.83; P < .001) among patients hospitalized during weeks with a high hospital COVID-19 burden (>30%) vs patients hospitalized prior to the pandemic. Black individuals with NSTEMI experienced a clinically insignificant 7% greater increase in the odds of mortality (aOR, 1.07; 95% CI, 1.00-1.15; P = .04) for each 10% increase in the COVID-19 hospital burden but no increases in readmissions or nonhome discharges or reductions in revascularization rates compared with White individuals. There were no differential increases in adverse outcomes among Hispanic compared with White patients with NSTEMI based on hospital COVID-19 burden. Increases in hospital COVID-19 burden were not associated with changes in outcomes or the use of revascularization in STEMI overall or by racial or ethnic group.

CONCLUSIONS AND RELEVANCE: This study found that while hospital COVID-19 burden was associated with worse treatment and outcomes for NSTEMI, race and ethnicity-associated inequities did not increase significantly during the pandemic. These findings suggest the need for additional efforts to mitigate outcomes associated with the COVID-19 pandemic for patients admitted with AMI when the hospital COVID-19 burden is substantially increased.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Glance LG, Joynt Maddox KE, Shang J, et al. The COVID-19 Pandemic and Associated Inequities in Acute Myocardial Infarction Treatment and Outcomes. JAMA Netw Open. 2023. PMID: 37624599. doi:10.1001/jamanetworkopen.2023.30327

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。